Literature DB >> 24898985

Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations.

Ajay Dara1, Abhay T Sangamwar.   

Abstract

INTRODUCTION: This review discusses the various drug therapeutic targets and latest technologies of anticancer patents from 10 Indian public-funded research organizations covering more than 150 esteemed institutes. We have identified and reported the leading assignee and inventors along with their collaboration network and, thereby, have analyzed the various patent trends, geographical distributions, citation maps, Derwent World Patents Index, international patent classification analysis and the like. AREAS COVERED: This article provides the insights of 1905 patent documents from 191 families and discusses in-depth anticancer technology through categorization studies at the level of drug discovery, drug development and treatment and diagnosis. In addition, various cancer targets were correlated with recent technologies so as to identify the white spaces for upcoming technologies. EXPERT OPINION: Over a period of 13 years (1990 - 2013) the main focus of Indian cancer research was in the field of synthetic chemistry and natural extracts followed by the pharmaceutical compositions and combinations, whereas, the white spaces for future cancer remedy were identified from research in the areas of cancer stem cell lines, vaccines, gene therapy, nano formulations with targeted drug delivery systems as core and latest technologies.

Entities:  

Keywords:  bibliometric analysis; cancer targets; patent landscape; patent trends; technology assessment

Mesh:

Substances:

Year:  2014        PMID: 24898985     DOI: 10.1517/13543776.2014.926329

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  1 in total

1.  Clearing the fog of anticancer patents from 1993-2013: through an in-depth technology landscape & target analysis from pioneer research institutes and universities worldwide.

Authors:  Ajay Dara; Abhay T Sangamwar
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.